Literature DB >> 14768716

The pathogenesis of systemic lupus erythematosus.

J J Manson1, D A Isenberg.   

Abstract

SLE is a complex, heterogeneous disease, the precise pathogenesis of which remains something of a mystery. In recent years our understanding has been advanced by the development of novel genetic and immunological techniques. Susceptibility to SLE has a genetic component and multiple putative genes are being investigated. The genes involved are likely to play a part in immune regulation. Central to the immune dysfunction seen in SLE is the presence of autoreactive B cells, which predominantly target nuclear antigens. In addition to evidence of aberrant B and T cell behaviour, lupus is associated with complement deficiencies, and abnormal cytokine function. A number of environmental triggers exist, and likely candidates include viral infection and exposure to UV light. Finally, evidence is accumulating that implicates apoptosis as a mechanism by which disease may be provoked and propagated.

Entities:  

Mesh:

Year:  2003        PMID: 14768716

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  17 in total

1.  Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.

Authors:  Dhanesh Pitidhammabhorn; Surasak Kantachuvesiri; Kitti Totemchokchyakarn; Yindee Kitiyanant; Sukathida Ubol
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

2.  Polymorphic variants of antioxidative defense enzymes and their gene-gene epistatic interactions in systemic lupus erythematode patients.

Authors:  Tatjana Jevtovic Stoimenov; Milena Despotovic; Sonja Stojanovic; Jelena Basic; Dušica Pavlovic
Journal:  Clin Rheumatol       Date:  2017-07-15       Impact factor: 2.980

3.  Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus.

Authors:  Ahmed A Emerah; Amal S El-Shal
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

Review 4.  Anti-TNF-alpha therapies in systemic lupus erythematosus.

Authors:  Lang-Jing Zhu; Xiao Yang; Xue-Qing Yu
Journal:  J Biomed Biotechnol       Date:  2010-06-22

5.  Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.

Authors:  Ling-Ling Zhou; Wei Wei; Jun-Feng Si; Dong-Ping Yuan
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

6.  Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis.

Authors:  Fang Sun; Jian Teng; Pengfei Yu; Wenshuang Li; Jing Chang; Honglei Xu
Journal:  Exp Ther Med       Date:  2018-01-05       Impact factor: 2.447

7.  Enhanced binding of circulating SLE autoantibodies to catecholestrogen-copper-modified DNA.

Authors:  Wahid Ali Khan; Safia Habib; Wajid Ali Khan; Khursheed Alam
Journal:  Mol Cell Biochem       Date:  2008-06-10       Impact factor: 3.396

8.  Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus.

Authors:  Eszter Kohut; Melinda Hajdu; Péter Gergely; László Gopcsa; Katalin Kilián; Katalin Pálóczi; László Kopper; Anna Sebestyén
Journal:  Pathol Oncol Res       Date:  2008-11-20       Impact factor: 3.201

9.  Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.

Authors:  Langjing Zhu; Xiao Yang; Weiying Chen; Xiaoyan Li; Yulian Ji; Haiping Mao; Jing Nie; Xueqing Yu
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 3.650

10.  Association of the genetic polymorphisms of the ACE gene and the eNOS gene with lupus nephropathy in northern Chinese population.

Authors:  X Li; J An; R Guo; Z Jin; Y Li; Y Zhao; F Lu; H Lian; P Liu; Y Zhao; X Jin
Journal:  BMC Med Genet       Date:  2010-06-14       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.